Lotta Jussila
About
In The Last Decade
Lotta Jussila
20 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 3.7k
- Molecular Biology 3.1k
- Surgery 1.1k
- Physiology 955
- Cellular and Molecular Neuroscience 447
Countries citing papers authored by Lotta Jussila
This map shows the geographic impact of Lotta Jussila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotta Jussila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotta Jussila more than expected).
Fields of papers citing papers by Lotta Jussila
This network shows the impact of papers produced by Lotta Jussila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotta Jussila. The network helps show where Lotta Jussila may publish in the future.
Co-authorship network of co-authors of Lotta Jussila
This figure shows the co-authorship network connecting the top 25 collaborators of Lotta Jussila. A scholar is included among the top collaborators of Lotta Jussila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotta Jussila. Lotta Jussila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 71 | |
| 2 | Lymphangiogenesis and cancer metastasis breakdown → | 647 |
| 3 | Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. | 67 |
| 4 | 312 | |
| 5 | Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3 breakdown → | 612 |
| 6 | 53 | |
| 7 | Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice breakdown → | 518 |
| 8 | 459 | |
| 9 | 305 | |
| 10 | 39 | |
| 11 | 43 | |
| 12 | 9 | |
| 13 | 178 | |
| 14 | 117 | |
| 15 | 70 | |
| 16 | 275 | |
| 17 | 62 | |
| 18 | Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. | 258 |
| 19 | Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3 breakdown → | 648 |
| 20 | 51 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.